COPD Clinical Trials in Chicago

Showing 1-20 of 116 trials

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

NCT07119229

A study taking place at multiple sites in the United States, Europe and Brazil to evaluate how well a new therapy for severe COPD/emphysema works, and how safe it is.

Emphysema or COPDEmphysemaCOPD

Pulmair Medical, Inc.60 participantsStarted Mar 2026

Chicago, Illinois, United States • Boston, Massachusetts, United States

RECRUITINGPhase 32.2 miles

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT05878769

The purpose of this study is to assess the long-term safety and to explore the efficacy of astegolimab in participants with chronic obstructive pulmonary disease (COPD) who have completed the 52-week placebo-controlled treatment period in parent studies GB43311 or GB44332.

Chronic Obstructive Pulmonary Disease

Hoffmann-La Roche2,000 participantsStarted Jun 2023

Birmingham, Alabama, United States • Dothan, Alabama, United States • Jasper, Alabama, United States +479 more locations

Page 1 of 6Next

A Multi Center Study Testing a New Implant for Adults With Severe Emphysema

A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

COPD Trials in Other Cities

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

Telehealth Education Leveraging Electronic Transitions Of Care for COPD Patients

Study of COPD Subgroups and Biomarkers

COPD Resources, Education, and Activity Designed for You Study

Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With a History of Frequent Exacerbations

SPIROMICS Study of Early COPD Progression (SOURCE)

Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD)

Long-term Efficacy and Safety of Tozorakimab in Participants With Chronic Obstructive Pulmonary Disease With a History of Exacerbations (PROSPERO).

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Frespaciguat (MK-5475) INSIGNIA-PH-COPD: A Study of the Efficacy and Safety of Frespaciguat (an Inhaled sGC Stimulator) in Adults With PH-COPD

Pivotal Study to Assess the Efficacy, Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Mechanistic Study of the Effect of Itepekimab on Airway Inflammation in Patients With COPD

A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough

Global Utilization And Registry Database for Improved preservAtion of doNor LUNGs

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

A Study to Evaluate the Effect of Budesonide, Glycopyrronium, Formoterol Fumarate (BGF) Metered Dose Inhaler (MDI), Budesonide and Formoterol Fumarate (BFF) MDI and Placebo MDI on Exercise Parameters in Participants With Chronic Obstructive Pulmonary Disease (COPD).

Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation

Other Conditions in Chicago